Belgium· BE-AMP-SAM131826-00
Suprefact Nasal 0.1 mg
A buserelin product containing buserelin acetate, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Buserelin is registered in 8 of 19 countries.
Countries holding a registration under ATC L02AE01 (buserelin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Buserelin · ATC L02AE01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Buserelin Acetate
- Manufacturer
- Sanofi Belgium
- Country
- Belgium (BE)
- ATC code
- L02AE01
- ATC class
- Buserelin
- Defined daily dose
- 0.11 mg, Implantat
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb0432971
- be_apb0727990
- be_apb0895946
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buserelin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSUPREFACT 100 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASALCheplapharm Arzneimittel Gmbh
- FinlandSuprefactsanofi-Aventis Oy
- United KingdomBuserelin 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- SwedenSuprecur 0,15 mg/dos Nässpray, lösningCheplapharm Arzneimittel GmbH
- ItalySUPREFACT*1 fiala SC 5,5 ml 1 mg/mlCHEPLAPHARM ARZNEIMITTEL GMBH
- GermanyMetrelefCheplapharm Arzneimittel Gmbh
- NetherlandsSuprefact Depot 3 maanden, implantatiestift 9,45 mgMedcor Pharmaceuticals B.V.
- CanadaSUPREFACTCHEPLAPHARM ARZNEIMITTEL GMBH
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Suprecur, Suprefact
- Bulgaria · Супрефакт Депо 3 Месеца
- Germany · Profact Depot, Profact Pro Injectione
- Spain · Suprefact, Suprefact Depot
- United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
- Greece · Suprefact Depot 3 Μήνεσ
- Hungary · Suprefact
- Italy · Suprefact, Suprefact Depot
- Netherlands · Suprefact Depot
- Sweden · Suprecur, Suprefact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44dbea7c-c06d-4a14-b3cc-201dd3d90e09 GET /v1/drugs/44dbea7c-c06d-4a14-b3cc-201dd3d90e09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nasal spray, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Suprefact Nasal 0.1 mg",
"name_fr": "Suprefact Nasal 0.1 mg",
"name_nl": "Suprefact Nasal 0.1 mg",
"amp_code": "SAM131826-00",
"strengths": [
"0.1050",
"0.1050",
"0.1000",
"0.1000"
],
"pack_count": 2,
"substances": [
"Buserelin Acetate",
"Buserelin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Buserelin",
"authorisation_numbers": [
"BE131826"
]
}See everything about buserelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.